Translational Development Acquisition Corp.NASDAQ: TDAC

TDAC reports 85% shareholder retention, $156.8M remaining in trust after extension vote

· Issued by Translational Development Acquisition Corp.

TDAC announced that 85% of shareholders did not redeem, leaving $156.8 million in its trust following the extension vote.

Key Highlights:

  • 14,651,303 Class A shares remained post-redemption, representing 85% retention and $156.8mm in trust.
  • 2,598,697 Class A shares were redeemed in connection with the June 17, 2026 extension vote.
  • 95% of votes cast were in favor of the extension, enabling continued pursuit of the ProLogium merger.
  • TDAC reaffirmed the proposed business combination with ProLogium, a leader in lithium ceramic battery technology targeting multiple growth markets.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Earlier from Translational Development Acquisition

All Translational Development Acquisition news releases